BIORESTORATIVE THERAPIES, INC. (BRTX) Operating cash flow 2016–2025
BIORESTORATIVE THERAPIES, INC. (BRTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$10.8MFY2025 · since FY2016: -$5.0M → -$10.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.8M | -31.1% |
| FY2024 | -$8.2M | -28.0% |
| FY2023 | -$6.4M | -8.7% |
| FY2022 | -$5.9M | -77.6% |
| FY2021 | -$3.3M | -69.5% |
| FY2020 | -$2.0M | +71.6% |
| FY2019 | -$6.9M | -35.5% |
| FY2018 | -$5.1M | -32.5% |
| FY2017 | -$3.9M | +23.0% |
| FY2016 | -$5.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BRTX financial trends
BRTX RevenueBRTX Net incomeBRTX Net marginBRTX Gross profitBRTX Gross marginBRTX Operating incomeBRTX Operating marginBRTX Free cash flowBRTX Capital expendituresBRTX Return on equityBRTX Stock buybacksBRTX Dividends paidBRTX Total assetsBRTX Total liabilitiesBRTX Shareholders’ equityBRTX overview →